icon_loop icon_cart icon_arrow-down icon_pick-winners icon_make-better-decisions icon_gofaster-gosmarter icon_equio icon_custom-research icon_conquer-the-wild icon_be-anonymous-and-secure icon_analyst-reports icon_access-realtime-data icon_youtube icon_twitter icon_linkedin icon_facebook

Brazil Patient Participation Levels


  • An estimated 22.2 million Brazilians suffer from chronic pain in the lower back and neck.
  • Were Brazil to legalize medical cannabis, within the first 36 months of sales the number of qualified patients could reach 959,000 under a restrictive list of qualifying conditions (i.e., not including chronic pain), or roughly 3.4 million under an expansive list of conditions (covering chronic pain).
  • An expansive program featuring chronic pain as a qualifying condition and patient counts of 3.4 million patients would translate to annual revenues of roughly BRL 4.4 billion (USD 1.4 billion).